Taros – Welab collaboration agreement

Barcelona, April 12th, 2023
We are proud to announce that Welab Barcelona, the drug discovery & development platform of Leitat, has signed a strategic collaboration agreement with Taros Chemicals, a leading German small molecule contract research organization. The combination of Taros’ small molecule contract research and manufacturing capabilities with Welab’s longstanding expertise with drug discovery projects in a cutting-edge R&D environment will support clients in getting their end-to-end discovery and development programs delivered.